Antiproliferative Activities of Cynaropicrin and Related Compounds against Cancer Stem Cells

Kousuke Araki,Minami Hara,Shohei Hamada,Takahiro Matsumoto,Seikou Nakamura
DOI: https://doi.org/10.1248/cpb.c23-00811
2024-02-20
Chemical and Pharmaceutical Bulletin
Abstract:Glioblastoma (GBM) has a high mortality rate despite the availability of various cancer treatment options. Although cancer stem cells (CSCs) have been associated with poor prognosis and metastasis, and play an important role in the resistance to existing anticancer drugs and radiation; no CSC-targeting drugs are currently approved in clinical practice. Therefore, the development of antiproliferative agents against CSCs is urgently required. In this study, we evaluated the antiproliferative activities of 21 sesquiterpenoids against human GBM U-251 MG CSCs and U-251 MG non-CSCs. Particularly, the guaianolide sesquiterpene lactone cynaropicrin (1) showed strong antiproliferative activity against U-251 MG CSCs (IC<sub>50</sub> = 20.4 µM) and U-251 MG non-CSCs (IC<sub>50</sub> = 10.9 µM). Accordingly, we synthesized six derivatives of 1 and investigated their structure-activity relationships. Most of the guaianolide sesquiterpene lactones with the α-methylene-γ-butyrolactone moiety showed antiproliferative activities against U-251 MG cells. We conclude that the 5,7,5-ring and the α-methylene-γ-butyrolactone moiety are both important for antiproliferative activities against U-251 MG cells. The results of this study suggest that the α,β-unsaturated carbonyl moiety, which has recently become a research hotspot in drug discovery, is the active center of 1. Therefore, we consider 1 as a potential lead for developing novel drugs targeting CSCs.
pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
What problem does this paper attempt to address?